-
2023
-
FDA approves drug which helps to slow progression of rare form of MND
-
National Institute for Health and Care Excellence approves expanded use of Yescarta and Tecartus
-
CHMP recommends approval for GSK’s RSV vaccine candidate
-
Janssen Gets EU Approval for Prostate Cancer Drug Akeega
-
Trefoil Therapeutics reports new findings from FECD therapy trial
-
IN8bio’s INB-400, INB-410 GMB Treatments Designated Orphan Drug by FDA
-
Avidity Biosciences Inc. Granted FDA Fast Track Designation for Antibody AOC 1044
-
AstraZeneca and Ionis’ ATTRv-PN therapy meets trial endpoints
-
Xortx Gets Orphan Drug Nod for Polycystic Kidney Disease
-
Trinity team develops promising gene therapy for glaucoma